frontline transplant-ineligible mm treatment
Published 5 years ago • 69 plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
4:59
frontline treatment of transplant-ineligible mm: a changing landscape
-
2:13
frontline treatment of transplant eligible patients with myeloma: current approach & future changes
-
2:18
evolving treatment options in ndmm: transplant-eligible and transplant-ineligible patients
-
2:53
achieving functional cure in transplant-eligible and transplant-ineligible multiple myeloma
-
11:00
what are monoclonal antibodies?
-
9:25
mgus diagnosis: a step-by-step approach
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
4:51
the current frontline treatment strategy in multiple myeloma
-
1:36
the future of frontline treatment in all: immunotherapy
-
1:27
frontline therapy for multiple myeloma
-
1:35
the impact of frontline maintenance therapy on myeloma patients in the uk
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
3:04
individualizing treatment in transplant-eligible & transplant-ineligible ndmm
-
2:23
treatment options for transplant-ineligible patients with multiple myeloma
-
3:59
induction and front-line therapy for myeloma
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml
-
11:38
frontline treatment for young multiple myeloma patients
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
0:59
treatment approaches for transplant-eligible and transplant-ineligbile myeloma patients